GBS Inc. also files under INBS; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Simeonidis Harry | Chief Executive Officer | Grant(A) | 9K | — | $0 |
| Mar 18, 2026 | Simeonidis Harry | Chief Executive Officer | Grant(A) | 21K | — | $0 |
| Mar 18, 2026 | Hurd Jonathan Scott | Director | Grant(A) | 5K | — | $0 |
| Mar 18, 2026 | Isenberg Jason | Director | Grant(A) | 5K | — | $0 |
| Mar 18, 2026 | Sakiris Spiro Kevin | Chief Financial Officer | Grant(A) | 9K | — | $0 |
| Mar 18, 2026 | Sakiris Spiro Kevin | Chief Financial Officer | Grant(A) | 21K | — | $0 |
| Mar 18, 2026 | Fraser Nicola Marion | Director | Grant(A) | 5K | — | $0 |
| Mar 18, 2026 | Boyages Steven Constantine | Director | Grant(A) | 5K | — | $0 |
| Sep 25, 2024 | Sakiris Spiro Kevin | Chief Financial Officer | Grant(A) | 35K | — | $0 |
| Sep 25, 2024 | Simeonidis Harry | Chief Executive Officer | Grant(A) | 40K | — | $0 |
| Mar 20, 2024 | Sakiris Spiro Kevin | Chief Financial Officer | Option exercise(X) | 9K | — | — |
| Mar 20, 2024 | Sakiris Spiro Kevin | Chief Financial Officer | Option exercise(X) | 9K | — | $0 |
| Oct 4, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 113K | — | — |
| Oct 4, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 113K | — | — |
| Oct 4, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 113K | — | — |
| Oct 4, 2023 | Towers Christopher | Director | Buy(P) | 9K | — | — |
| Oct 4, 2023 | Towers Christopher | Director | Buy(P) | 9K | — | — |
| Oct 4, 2023 | Towers Christopher | Director | Buy(P) | 9K | — | — |
| Sep 1, 2023 | Simeonidis Harry | CEO | Buy(P) | 50 | $1.85 | $93 |
| Aug 31, 2023 | Simeonidis Harry | CEO | Buy(P) | 100 | $1.92 | $192 |
| May 10, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Conversion(C) | 16K | — | $0 |
| May 10, 2023 | Sakiris Spiro Kevin | Chief Financial Officer | Conversion(C) | 2K | $5.80 | $14K |
| Dec 22, 2022 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 16K | $0.87 | $14K |
| Dec 22, 2022 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 48K | $0.13 | $6K |
| Oct 10, 2022 | Fisher Lawrence B | Director | Grant(A) | 15K | — | $0 |
| Oct 10, 2022 | Margelis George | Director | Grant(A) | 15K | — | $0 |
| Oct 10, 2022 | Towers Christopher | Director | Grant(A) | 15K | — | $0 |
| Oct 10, 2022 | Hurd Jonathan Scott | Director | Grant(A) | 15K | — | $0 |
| Oct 10, 2022 | Simeonidis Harry | President | Grant(A) | 80K | — | $0 |
| Oct 10, 2022 | Sakiris Spiro Kevin | Chief Financial Officer | Grant(A) | 75K | — | $0 |
| Oct 10, 2022 | Boyages Steven Constantine | Interim CEO and Chairperson, Director | Grant(A) | 75K | — | $0 |
| Jun 22, 2022 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 5K | $0.65 | $3K |
| Jun 17, 2022 | Sakiris Spiro Kevin | ChiefFinancial Officer | Buy(P) | 16K | $0.61 | $10K |
| Feb 17, 2022 | Life Science Biosensor Diagnostics Pty Ltd | Insider | Sell(S) | 576K | $0.51 | $294K |
| Feb 16, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.63 | $63K |
| Feb 15, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.68 | $68K |
| Feb 14, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.70 | $70K |
| Feb 11, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.75 | $75K |
| Feb 10, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.84 | $84K |
| Feb 9, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.86 | $86K |
| Feb 8, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.89 | $89K |
| Feb 2, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.92 | $92K |
| Jan 31, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.90 | $90K |
| Jan 28, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $0.92 | $92K |
| Jan 27, 2022 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $1.00 | $100K |
| Dec 30, 2021 | Parmakellis Tom | Director | Buy(P) | 5K | $1.55 | $7K |
| Dec 17, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 200K | $1.49 | $298K |
| Dec 16, 2021 | Parmakellis Tom | Director | Buy(P) | 3K | $1.69 | $5K |
| Dec 6, 2021 | Sakiris Spiro Kevin | ChiefFinancial Officer | Buy(P) | 10K | $1.70 | $17K |
| Nov 30, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 250K | $1.87 | $468K |
| Nov 29, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $1.69 | $169K |
| Nov 24, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $1.64 | $164K |
| Nov 9, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 300K | $2.02 | $606K |
| Oct 21, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 248K | $2.26 | $561K |
| Oct 20, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 24K | $2.25 | $54K |
| Oct 19, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 16K | $2.25 | $37K |
| Oct 14, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 101K | $2.18 | $220K |
| Oct 13, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 59K | $2.25 | $132K |
| Oct 12, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $2.13 | $213K |
| Oct 8, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 200K | $2.30 | $460K |
| Sep 28, 2021 | Parmakellis Tom | Director | Buy(P) | 1K | $2.40 | $2K |
| Sep 28, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 200K | $2.48 | $496K |
| Sep 24, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 200K | $2.66 | $532K |
| Sep 23, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $2.77 | $277K |
| Sep 22, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $2.80 | $280K |
| Sep 21, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $2.83 | $283K |
| Sep 20, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 100K | $2.90 | $290K |
| Sep 17, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Sell(S) | 45K | $3.29 | $149K |
| Jun 21, 2021 | Parmakellis Tom | Director | Buy(P) | 1K | $4.44 | $4K |
| May 19, 2021 | Sakiris Spiro Kevin | Chief Financial Officer | Buy(P) | 10K | $3.07 | $31K |
| Mar 2, 2021 | Gavrilenko Victoria | Director | Buy(P) | 37 | $8.09 | $296 |
| Feb 24, 2021 | Towers Christopher | Director | Buy(P) | 800 | $6.84 | $5K |
| Jan 18, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Option exercise(X) | 118K | — | — |
| Jan 18, 2021 | Life Science Biosensor Diagnostics Pty Ltd | 10% Owner | Option exercise(X) | 118K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: GBS Inc., SEC CIK 0001725430. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under GBS and shows every filing by that issuer (also filed as INBS).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for GBS